This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a tert-butoxycarbonyl (Boc) protecting group and a difluorophenyl moiety, makes it valuable in the development of protease inhibitors and other therapeutic agents targeting specific enzymes or receptors. The Boc group can be easily removed under mild acidic conditions, allowing for further functionalization in complex drug synthesis processes. Additionally, the difluorophenyl group enhances the compound's binding affinity and metabolic stability, making it a crucial component in the design of drugs for treating conditions such as hypertension, inflammation, and certain cancers. Its application is particularly prominent in the production of small molecule drugs that require precise stereochemistry for optimal efficacy.